CYP-Mediated Therapeutic Protein-Drug Interactions: Clinical Findings, Proposed Mechanisms and Regulatory Implications

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.5, 2010-05, pp. : 295-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP-Mediated Clozapine Interactions: How Predictable Are They?

Current Drug Metabolism, Vol. 8, Iss. 4, 2007-05 ,pp. : 307-313

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interactions with St Johns Wort: Mechanisms and Clinical Implications

By Marcus Mannel

Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. : 773-797

Adis International

Access to resources Recommend Favorite

Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications

By Logan Randall Funk Ryan S Axcell Erick Krise Jeffrey P

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 8, 2012-08 ,pp. : 943-958

Informa Healthcare

Access to resources Recommend Favorite

Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression

By Pondugula Satyanarayana R Dong Hanqing Chen Taosheng

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite

Drug Interactions with Antipsychotic Agents: Incidence and Therapeutic Implications

By ZumBrunnen T.L. Jann M.W.

CNS Drugs, Vol. 9, Iss. 5, 1998-05 ,pp. : 381-401

Adis International

Access to resources Recommend Favorite